- Home
- RNP vs TNDM Comparison
RNP vs TNDM Comparison
Compare RNP & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNP
- TNDM
- Stock Information
- Founded
- RNP 2003
- TNDM 2006
- Country
- RNP United States
- TNDM United States
- Employees
- RNP N/A
- TNDM N/A
- Industry
- RNP Investment Managers
- TNDM Medical/Dental Instruments
- Sector
- RNP Finance
- TNDM Health Care
- Exchange
- RNP Nasdaq
- TNDM Nasdaq
- Market Cap
- RNP 1.1B
- TNDM 1.1B
- IPO Year
- RNP N/A
- TNDM 2013
- Fundamental
- Price
- RNP $22.66
- TNDM $15.89
- Analyst Decision
- RNP
- TNDM Buy
- Analyst Count
- RNP 0
- TNDM 13
- Target Price
- RNP N/A
- TNDM $32.15
- AVG Volume (30 Days)
- RNP 117.6K
- TNDM 1.8M
- Earning Date
- RNP 01-01-0001
- TNDM 08-06-2025
- Dividend Yield
- RNP 7.94%
- TNDM N/A
- EPS Growth
- RNP N/A
- TNDM N/A
- EPS
- RNP N/A
- TNDM N/A
- Revenue
- RNP N/A
- TNDM $982,951,000.00
- Revenue This Year
- RNP N/A
- TNDM $8.91
- Revenue Next Year
- RNP N/A
- TNDM $11.04
- P/E Ratio
- RNP N/A
- TNDM N/A
- Revenue Growth
- RNP N/A
- TNDM 27.65
- 52 Week Low
- RNP $15.52
- TNDM $14.31
- 52 Week High
- RNP $21.27
- TNDM $47.60
- Technical
- Relative Strength Index (RSI)
- RNP 55.70
- TNDM 42.33
- Support Level
- RNP $22.31
- TNDM $14.31
- Resistance Level
- RNP $22.99
- TNDM $16.35
- Average True Range (ATR)
- RNP 0.24
- TNDM 0.86
- MACD
- RNP -0.04
- TNDM 0.14
- Stochastic Oscillator
- RNP 50.74
- TNDM 56.23
About RNP Cohen & Steers REIT and Preferred and Income Fund Inc.
Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.